Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Bermudez

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
ACS Chemical Neuroscience|August 3, 2023
Side Groups Convert the α7 Nicotinic Receptor Agonist Ether Quinuclidine into a Type I Positive Allosteric ModulatorFranco Viscarra, Juan Facundo Chrestia, Yaima Sanchez, et al.
The Journal of Biological Chemistry|June 18, 2014
Non-equivalent ligand selectivity of agonist sites in (α4β2)2α4 nicotinic acetylcholine receptors: a key determinant of agonist efficacySimone Mazzaferro, Federica Gasparri, Karina New, et al.
The Korean Journal of Internal Medicine|November 8, 2014
Parvimonas micra chest wall abscess following transthoracic lung needle biopsyLuis Gorospe, Isabel Bermudez-Coronel-Prats, Carol F Gomez-Barbosa, et al.
European Journal of Pharmacology|March 28, 2006
C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonistsJ Andrés Abin-Carriquiry, Merja H Voutilainen, Jacques Barik, et al.
European Journal of Pharmacology|March 1, 2005
Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanismChantal J G M Smulders, Ruud Zwart, Isabel Bermudez, et al.
Molecular Pharmacology|June 16, 2010
Molecular determinants for competitive inhibition of alpha4beta2 nicotinic acetylcholine receptorsPatricio Iturriaga-Vásquez, Annalisa Carbone, Olimpo García-Beltrán, et al.
Toxicology Letters|January 22, 2021
Molecular determinants of binding of non-oxime bispyridinium nerve agent antidote compounds to the adult muscle nAChRMax Epstein, Karan Bali, Thomas J Piggot, et al.
Bioorganic & Medicinal Chemistry|April 9, 2013
Neonicotinic analogues: selective antagonists for α4β2 nicotinic acetylcholine receptorsManuel Faundez-Parraguez, Nicolas Farias-Rabelo, Juan Pablo Gonzalez-Gutierrez, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Simulations support the interaction of the SARS-CoV-2 spike protein with nicotinic acetylcholine receptorsA Sofia F Oliveira, Amaurys Avila Ibarra, Isabel Bermudez, et al.
Biophysical Journal|February 20, 2021
A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptorsA Sofia F Oliveira, Amaurys Avila Ibarra, Isabel Bermudez, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
ACS Chemical Neuroscience|August 3, 2023
Side Groups Convert the α7 Nicotinic Receptor Agonist Ether Quinuclidine into a Type I Positive Allosteric ModulatorFranco Viscarra, Juan Facundo Chrestia, Yaima Sanchez, et al.
The Journal of Biological Chemistry|June 18, 2014
Non-equivalent ligand selectivity of agonist sites in (α4β2)2α4 nicotinic acetylcholine receptors: a key determinant of agonist efficacySimone Mazzaferro, Federica Gasparri, Karina New, et al.
The Korean Journal of Internal Medicine|November 8, 2014
Parvimonas micra chest wall abscess following transthoracic lung needle biopsyLuis Gorospe, Isabel Bermudez-Coronel-Prats, Carol F Gomez-Barbosa, et al.
European Journal of Pharmacology|March 28, 2006
C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonistsJ Andrés Abin-Carriquiry, Merja H Voutilainen, Jacques Barik, et al.
European Journal of Pharmacology|March 1, 2005
Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanismChantal J G M Smulders, Ruud Zwart, Isabel Bermudez, et al.
Molecular Pharmacology|June 16, 2010
Molecular determinants for competitive inhibition of alpha4beta2 nicotinic acetylcholine receptorsPatricio Iturriaga-Vásquez, Annalisa Carbone, Olimpo García-Beltrán, et al.
Toxicology Letters|January 22, 2021
Molecular determinants of binding of non-oxime bispyridinium nerve agent antidote compounds to the adult muscle nAChRMax Epstein, Karan Bali, Thomas J Piggot, et al.
Bioorganic & Medicinal Chemistry|April 9, 2013
Neonicotinic analogues: selective antagonists for α4β2 nicotinic acetylcholine receptorsManuel Faundez-Parraguez, Nicolas Farias-Rabelo, Juan Pablo Gonzalez-Gutierrez, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Simulations support the interaction of the SARS-CoV-2 spike protein with nicotinic acetylcholine receptorsA Sofia F Oliveira, Amaurys Avila Ibarra, Isabel Bermudez, et al.
Biophysical Journal|February 20, 2021
A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptorsA Sofia F Oliveira, Amaurys Avila Ibarra, Isabel Bermudez, et al.
Pageof 6